Abiopharma

ImmunoPrecise - ImmunoPrecise Releases New Findings ShowingLENSai™ Quickly Flags Anti-Drug-AntibodyRisk—Long Before the Clinic

ImmunoPrecise Releases New Findings Showing LENSai™ Quickly Flags Anti-Drug-Antibody Risk—Long Before the Clinic

Trinity Biotech Unveils CGM+: An AI-Native Platform Targeting the $260 Billion AI Wearable Market

New Form 8-K - Bausch Health Companies Inc. Filed: 2025-07-24 AccNo: 0001193125-25-163860 Size: 155 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

Hyperfine Swoop® AI-Powered Portable MRI System Showcased in Clinical Studies Designed to Broaden Access to Dementia Care

CoyaTherapeutics - Coya Therapeutics Announces Publication of Scientific Research Linking Inflammation and Oxidative Stress to the Progression of Parkinson’s Disease

Aditxt’s Subsidiary Pearsanta Receives an Invitation to Submit Full Proposal for the U.S. Department of Defense Pilot Award for the Development of its Mitomic® Ovarian Test

Coya Therapeutics Announces Publication of Scientific Research Linking Inflammation and Oxidative Stress to the Progression of Parkinson’s Disease

New Form SC TO-T/A - Verve Therapeutics, Inc. Filed: 2025-07-24 AccNo: 0001193125-25-163856 Size: 52 KB

Candel Therapeutics Receives EMA Orphan Designation for CAN-2409 for the Treatment of Pancreatic Cancer

Novavaxs H5N1 Vaccine Candidate Demonstrates Immunogenicity in Preclinical Study

New Form 8-K - Integer Holdings Corp Filed: 2025-07-24 AccNo: 0001171843-25-004663 Size: 634 KB Item 2.02: Results of Operations and Financial Condition Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

Vir Biotechnology - Vir Biotechnology Announces First Patient Dosed in Phase 1 Clinical Trial of EGFR-Targeting PRO-XTEN™Dual-Masked T-Cell Engager VIR-5525 for the Treatment of Solid Tumors

Vir Biotechnology Announces First Patient Dosed in Phase 1 Clinical Trial of EGFR-Targeting PRO-XTEN™ Dual-Masked T-Cell Engager VIR-5525 for the Treatment of Solid Tumors

Water Tower Research Highlights Ainos SmellTech Platform AI Nose as Foundational AI Innovation